PALISADE BIO, INC. (PALI) Return on equity 2016–2025
PALISADE BIO, INC. (PALI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-13.0%FY2025 · since FY2016: -186.0% → -13.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13.0% | +179.7 pp |
| FY2024 | -192.7% | -84.0 pp |
| FY2023 | -108.7% | +5.5 pp |
| FY2022 | -114.3% | — |
| FY2018 | -81.4% | +102.6 pp |
| FY2017 | -184.0% | +2.0 pp |
| FY2016 | -186.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice